These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 17033807

  • 1. Predictive risk factors for coronary artery abnormalities in Kawasaki disease.
    Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2007 May; 166(5):421-5. PubMed ID: 17033807
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH, Chen MR, Hwang FY, Kao HA, Hung HY, Hsu CH.
    Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA, Corydon KE, Shulman ST.
    J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
    [Abstract] [Full Text] [Related]

  • 5. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M, Ohki H, Tsuchihashi T, Yamagishi H, Katada Y, Yamada K, Yamashita Y, Sugaya A, Komiyama O, Shiro H.
    Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
    [Abstract] [Full Text] [Related]

  • 6. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 7. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.
    Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Feb; 168(2):157-62. PubMed ID: 18478263
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
    Terai M, Shulman ST.
    J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [Abstract] [Full Text] [Related]

  • 10. Low risk of treatment resistance in Down syndrome with Kawasaki disease.
    Takatsuki S, Ogata S, Ishii M, Yokozawa M, Ono M, Fujiwara M, Ida H, Motomura H, Moriuchi H, Taketazu M, Kawamura Y, Kawano T, Izumi T, Shiono J, Tsuchiya S, Tsuchiya K, Goushi T, Ichida F, Saji T.
    Pediatr Int; 2017 Dec; 59(12):1236-1239. PubMed ID: 28960680
    [Abstract] [Full Text] [Related]

  • 11. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K.
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y.
    Circulation; 2003 Jul 22; 108(3):325-30. PubMed ID: 12835221
    [Abstract] [Full Text] [Related]

  • 13. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 22; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 14. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm.
    Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K.
    Pediatr Int; 2002 Aug 22; 44(4):353-7. PubMed ID: 12139556
    [Abstract] [Full Text] [Related]

  • 15. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L, Salama A, Uthaman B, Kumar A, Selvan J.
    Int J Cardiol; 1999 Apr 30; 69(1):71-6. PubMed ID: 10362375
    [Abstract] [Full Text] [Related]

  • 16. Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.
    Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP, Texter K, Ramilo O, Burns JC, Tremoulet AH.
    Pediatr Infect Dis J; 2015 Dec 30; 34(12):1315-8. PubMed ID: 26353031
    [Abstract] [Full Text] [Related]

  • 17. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, Iemura M, Ishii M, Kato H.
    Pediatr Int; 1999 Feb 30; 41(1):1-7. PubMed ID: 10200128
    [Abstract] [Full Text] [Related]

  • 18. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 30; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 19. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
    Hwang KP, Wu JR, Huang LY, Liou CC, Huang TY.
    Kaohsiung J Med Sci; 1996 Mar 30; 12(3):159-66. PubMed ID: 8709183
    [Abstract] [Full Text] [Related]

  • 20. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul 30; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.